Ruiz-Rubio Leire, Alonso María Luz, Pérez-Álvarez Leyre, Alonso Rosa Maria, Vilas Jose Luis, Khutoryanskiy Vitaliy V
Macromolecular Chemistry Group (LABQUIMAC), Department of Physical Chemistry, Faculty of Science and Technology, University of the Basque Country, UPV/EHU, Barrio Sarriena, s/n, 48940 Leioa, Spain.
Analytical Chemistry Department, Faculty of Science and Technology, University of the Basque Country, UPV/EHU, Barrio Sarriena, s/n, 48940 Leioa, Spain.
Polymers (Basel). 2018 Feb 11;10(2):175. doi: 10.3390/polym10020175.
Poly(2-ethyl-2-oxazoline) has become an excellent alternative to the use of poly(ethylene glycol) in pharmaceutical formulations due to its valuable physicochemical and biological properties. This work presents a formulation of poorly-water soluble drug, hydrocortisone, using interpolymer complexes and physical blends of poly(2-ethyl-2-oxazoline)s and two Carbopols (Carbopol 974 and Carbopol 971) for oromucosal administration. The swelling, hydrocortisone release and mucoadhesive properties of a series of tablet formulations obtained by combination of different Carbopols with poly(2-ethyl-2-oxazoline)s of different molecular weights have been evaluated in vitro.
由于聚(2 - 乙基 - 2 - 恶唑啉)具有宝贵的物理化学和生物学特性,它已成为药物制剂中聚(乙二醇)使用的极佳替代品。这项工作展示了一种难溶性药物氢化可的松的制剂,该制剂使用了聚(2 - 乙基 - 2 - 恶唑啉)与两种卡波姆(卡波姆974和卡波姆971)的聚合物间复合物和物理混合物,用于口腔黏膜给药。通过将不同的卡波姆与不同分子量的聚(2 - 乙基 - 2 - 恶唑啉)组合获得的一系列片剂制剂的溶胀、氢化可的松释放和粘膜粘附特性已在体外进行了评估。